Consistent with the AML cell lines, downregulation of CHK1, WEE1, RAD51, c‐Myc, RRM2, p‐CDC25C, p‐CDK1 and p‐CDK2 was detected in both patient samples (Figure 4A and Figure S2A). This evidence concerns the gene CHEK1 and acute myeloid leukemia.